$USNU
Elite Health Systems Inc.

2023 Q3 Form 10-Q Financial Statement

#000114036123053308 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $151.0K
YoY Change -31.67%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $151.0K
YoY Change -31.67%
Operating Profit -$151.0K
YoY Change -31.67%
Interest Expense $1.000K
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.000K
YoY Change -100.64%
Pretax Income -$150.0K
YoY Change -60.21%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$127.0K
YoY Change -60.44%
Net Earnings / Revenue
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.02
COMMON SHARES
Basic Shares Outstanding 7.892M
Diluted Shares Outstanding 7.892M

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $559.0K
Short-Term Investments
Other Short-Term Assets $20.00K
YoY Change -61.54%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $579.0K
YoY Change -17.64%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $187.0K
YoY Change 23.03%
Other Assets $292.0K
YoY Change -38.66%
Total Long-Term Assets $292.0K
YoY Change -42.29%
TOTAL ASSETS
Total Short-Term Assets $579.0K
Total Long-Term Assets $292.0K
Total Assets $871.0K
YoY Change -27.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $191.0K
YoY Change -43.15%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $191.0K
Total Long-Term Liabilities
Total Liabilities $202.0K
YoY Change -41.79%
SHAREHOLDERS EQUITY
Retained Earnings -$2.380M
YoY Change 7.5%
Common Stock $2.950M
YoY Change 0.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $570.0K
YoY Change
Total Liabilities & Shareholders Equity $871.0K
YoY Change -27.96%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income -$127.0K
YoY Change -60.44%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
151000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-150000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-378000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-23000
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-57000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-127000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
522000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
878000
us-gaap Operating Expenses
OperatingExpenses
522000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7892185
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7892185
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7792185
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7792185
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7792185
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
151000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
496000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-44000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-110000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
0
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
0
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5370333
dei Entity Address Address Line1
EntityAddressAddressLine1
2400 Research Blvd, Suite 325
dei Entity Address City Or Town
EntityAddressCityOrTown
Rockville
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20850
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
208-8998
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7892185
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7892185
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7842185
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7842185
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
570000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1239000
CY2023Q3 us-gaap Minority Interest
MinorityInterest
99000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
217000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
58000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-15586
dei Entity Registrant Name
EntityRegistrantName
U.S. NeuroSurgical Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7892185
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
221000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
221000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-151000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1287000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-788000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2165000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
us-gaap Profit Loss
ProfitLoss
-788000
us-gaap Profit Loss
ProfitLoss
-2167000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-118000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-325000
us-gaap Net Income Loss
NetIncomeLoss
-670000
us-gaap Net Income Loss
NetIncomeLoss
-1842000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
23000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
393000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001089815
dei Document Type
DocumentType
10-Q
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-221000
CY2023Q3 us-gaap Interest Expense
InterestExpense
1000
CY2022Q3 us-gaap Interest Expense
InterestExpense
0
CY2023Q3 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
0
CY2022Q3 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
0
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-156000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-156000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-150000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-377000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-321000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7892185
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7892185
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7792185
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Operating Expenses
OperatingExpenses
878000
us-gaap Operating Income Loss
OperatingIncomeLoss
-522000
us-gaap Operating Income Loss
OperatingIncomeLoss
-878000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-266000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1287000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-266000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30000
CY2023Q3 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
0
CY2022Q3 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
30000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2023Q3 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
0
CY2022Q3 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
34000
us-gaap Lease Cost
LeaseCost
0
us-gaap Lease Cost
LeaseCost
31000
usnu Renovation Installation And Operation Agreement Period
RenovationInstallationAndOperationAgreementPeriod
P14Y
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001140361-23-053308-index-headers.html Edgar Link pending
0001140361-23-053308-index.html Edgar Link pending
0001140361-23-053308.txt Edgar Link pending
0001140361-23-053308-xbrl.zip Edgar Link pending
ef20012480_10q.htm Edgar Link pending
ef20012480_ex31-1.htm Edgar Link pending
ef20012480_ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ef20012480_10q_htm.xml Edgar Link completed
Show.js Edgar Link pending
usnu-20230930.xsd Edgar Link pending
usnu-20230930_cal.xml Edgar Link unprocessable
usnu-20230930_def.xml Edgar Link unprocessable
usnu-20230930_lab.xml Edgar Link unprocessable
usnu-20230930_pre.xml Edgar Link unprocessable